Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial
Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer revision identifier was updated from **v3.5.2** to **v3.5.3**, indicating a ClinicalTrials.gov page version refresh without changing the study details shown.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0, indicating a system/template update across the page.SummaryDifference0.0%

- Check45 days agoChange DetectedPage revision note updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check59 days agoChange DetectedA new citation for SARS-CoV-2 resistance analyses from the Phase 3 BIRCH study was added, and the earlier version of that citation was removed.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded Clin Infect Dis publication on BIRCH (2026) and removed older funding notice.SummaryDifference0.3%

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.